Tiziana Life Sciences Ltd. Common Shares
Symbol: TLSA (NASDAQ)
0.00
▼ (-100.00%) -1.740
Company Description:
Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease, and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.
Key Stats
- Today's Open: $0
- Today's High: $0
- Today's Low: $0
- Today's Volume: 0
- Yesterday Close: $1.74
- Yesterday High: $1.87
- Yesterday Low: $1.73
- Yesterday Volume: 277.93K
- Last Min Volume: 0
- Last Min High: $0
- Last Min Low: $0
- Last Min VWAP: $0
Company Profile
- Name: Tiziana Life Sciences Ltd. Common Shares
- Website: https://www.tizianalifesciences.com
- Listed Date: 2018-11-20
- Location: ,
- Market Status: Active
- CIK Number: 0001723069
- SIC Code:
- SIC description:
- Market Cap: $203.32M
- Round Lot: 100
- Outstanding Shares: 116.85M
- Asset Type: CS
RECENT FILINGS FOR TLSA
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-09 | 6-K | View |
| 2025-09-09 | 6-K | View |
| 2025-09-05 | 6-K | View |
| 2025-08-14 | 6-K | View |
| 2025-08-11 | 6-K | View |
| 2025-07-21 | 6-K | View |
| 2025-06-13 | 6-K | View |
| 2025-06-13 | 6-K | View |
| 2025-06-12 | SCHEDULE 13G | View |
| 2025-05-23 | 6-K | View |
| 2025-05-15 | 6-K | View |
| 2025-05-12 | 6-K | View |
| 2025-05-09 | 6-K | View |
| 2025-05-08 | 20-F/A | View |
| 2025-05-06 | 20-F | View |
| 2025-05-06 | 6-K | View |
| 2025-04-30 | NT 20-F | View |
| 2025-04-23 | 6-K | View |
| 2025-04-02 | 6-K | View |
| 2025-03-27 | EFFECT | View |
Latest News on TLSA